<li>avanafil<p>nitroglycerin sublingual, avanafil. Mechanism: additive vasodilation. Contraindicated. Potentially fatal hypotension.</p></li><li>bromocriptine<p>bromocriptine decreases effects of nitroglycerin sublingual by pharmacodynamic antagonism. Contraindicated.</p></li><li>cabergoline<p>cabergoline decreases effects of nitroglycerin sublingual by pharmacodynamic antagonism. Contraindicated.</p></li><li>dihydroergotamine<p>dihydroergotamine decreases effects of nitroglycerin sublingual by pharmacodynamic antagonism. Contraindicated.</p></li><li>dihydroergotamine intranasal<p>dihydroergotamine intranasal decreases effects of nitroglycerin sublingual by pharmacodynamic antagonism. Contraindicated.</p></li><li>ergoloid mesylates<p>ergoloid mesylates decreases effects of nitroglycerin sublingual by pharmacodynamic antagonism. Contraindicated.</p></li><li>ergonovine<p>ergonovine decreases effects of nitroglycerin sublingual by pharmacodynamic antagonism. Contraindicated.</p></li><li>ergotamine<p>ergotamine decreases effects of nitroglycerin sublingual by pharmacodynamic antagonism. Contraindicated.</p></li><li>methylergonovine<p>methylergonovine decreases effects of nitroglycerin sublingual by pharmacodynamic antagonism. Contraindicated.</p></li><li>riociguat<p>nitroglycerin sublingual, riociguat.
Either increases effects of the other by additive vasodilation. Contraindicated. Coadministration of nitrates or nitric oxide donors is contraindicated due to risk of hypotension.</p></li><li>sildenafil<p>nitroglycerin sublingual, sildenafil. Mechanism: additive vasodilation. Contraindicated. Potentially fatal hypotension.</p></li><li>tadalafil<p>nitroglycerin sublingual, tadalafil. Mechanism: additive vasodilation. Contraindicated. Potentially fatal hypotension.</p></li><li>vardenafil<p>nitroglycerin sublingual, vardenafil. Mechanism: additive vasodilation. Contraindicated. Potentially fatal hypotension.</p></li>